• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GAMER-Ad:一种生成重组腺病毒的新颖快速方法。

GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses.

作者信息

Hamdan Firas, Martins Beatriz, Feodoroff Michaela, Giannoula Yvonne, Feola Sara, Fusciello Manlio, Chiaro Jacopo, Antignani Gabriella, Grönholm Mikaela, Ylösmäki Erkko, Cerullo Vincenzo

机构信息

Laboratory of Immunovirotherapy (IVTLab), Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.

出版信息

Mol Ther Methods Clin Dev. 2021 Feb 4;20:625-634. doi: 10.1016/j.omtm.2021.01.014. eCollection 2021 Mar 12.

DOI:10.1016/j.omtm.2021.01.014
PMID:33718513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907680/
Abstract

Oncolytic adenoviruses have become ideal agents in the path toward treating cancer. Such viruses have been engineered to conditionally replicate in malignant cells in which certain signaling pathways have been disrupted. Other than such oncolytic properties, the viruses need to activate the immune system in order to sustain a long-term response. Therefore, oncolytic adenoviruses have been genetically modified to express various immune-stimulatory agents to achieve this. However, genetically modifying adenoviruses is very time consuming and labor intensive with the current available methods. In this paper, we describe a novel method we have called GAMER-Ad to genetically modify adenovirus genomes within 2 days. Our method entails the replacement of the gp19k gene in the E3 region with any given gene of interest (GOI) using Gibson Assembly avoiding the homologous recombination between the shuttle and the parental plasmid. In this manuscript as proof of concept we constructed and characterized three oncolytic adenoviruses expressing CXCL9, CXCL10, and interleukin-15 (IL-15). We demonstrate that our novel method is fast, reliable, and simple compared to other methods. We anticipate that our method will be used in the future to genetically engineer oncolytic but also other adenoviruses used for gene therapy as well.

摘要

溶瘤腺病毒已成为癌症治疗道路上的理想药物。这类病毒经过改造,可在某些信号通路被破坏的恶性细胞中进行条件性复制。除了这种溶瘤特性外,病毒还需要激活免疫系统以维持长期反应。因此,溶瘤腺病毒已被基因改造以表达各种免疫刺激剂来实现这一点。然而,使用现有的方法对腺病毒进行基因改造非常耗时且费力。在本文中,我们描述了一种我们称为GAMER-Ad的新方法,可在两天内对腺病毒基因组进行基因改造。我们的方法是使用吉布森组装法,用任何给定的感兴趣基因(GOI)替换E3区域中的gp19k基因,避免穿梭质粒与亲本质粒之间的同源重组。在本手稿中,作为概念验证,我们构建并表征了三种表达CXCL9、CXCL10和白细胞介素-15(IL-15)的溶瘤腺病毒。我们证明,与其他方法相比,我们的新方法快速、可靠且简单。我们预计,我们的方法未来将用于对溶瘤腺病毒以及其他用于基因治疗的腺病毒进行基因工程改造。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/ecb6fd08d11f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/d0452c5c2dd9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/51ccea06155d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/a2f7b6a8b1f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/102a6404c68d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/2f3048583441/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/087369a580ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/28724d1bc44b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/ecb6fd08d11f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/d0452c5c2dd9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/51ccea06155d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/a2f7b6a8b1f3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/102a6404c68d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/2f3048583441/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/087369a580ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/28724d1bc44b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/7907680/ecb6fd08d11f/gr7.jpg

相似文献

1
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses.GAMER-Ad:一种生成重组腺病毒的新颖快速方法。
Mol Ther Methods Clin Dev. 2021 Feb 4;20:625-634. doi: 10.1016/j.omtm.2021.01.014. eCollection 2021 Mar 12.
2
Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.通过大肠杆菌中的单步同源重组高效产生双异源启动子控制的溶瘤腺病毒载体
BMC Biotechnol. 2006 Aug 3;6:36. doi: 10.1186/1472-6750-6-36.
3
CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells.CCL21/IL21 武装溶瘤腺病毒增强了对 TERT 阳性肿瘤细胞的抗肿瘤活性。
Virus Res. 2016 Jul 15;220:172-8. doi: 10.1016/j.virusres.2016.05.002. Epub 2016 May 5.
4
A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.一种用于生成携带一个或两个转基因的溶瘤腺病毒载体的简化系统。
Cancer Gene Ther. 2008 Mar;15(3):173-82. doi: 10.1038/sj.cgt.7701105. Epub 2007 Dec 21.
5
Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.溶瘤腺病毒作为骨肉瘤的一种治疗方法:新希望
J Bone Oncol. 2016 Dec 14;9:41-47. doi: 10.1016/j.jbo.2016.12.001. eCollection 2017 Nov.
6
A three-plasmid system for construction of armed oncolytic adenovirus.一种构建武装溶瘤腺病毒的三质粒系统。
J Virol Methods. 2009 Dec;162(1-2):8-13. doi: 10.1016/j.jviromet.2009.07.011. Epub 2009 Jul 29.
7
Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.删除E3-6.7K/gp19K区域可降低野生型腺病毒在叙利亚仓鼠允许性肿瘤模型中的持久性。
Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12. Epub 2009 Feb 20.
8
Genetically modified adenoviruses against gliomas: from bench to bedside.抗胶质瘤的基因工程腺病毒:从实验台到临床应用
Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f.
9
Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.携带TRAIL和IL-12基因的溶瘤腺病毒联合治疗在体外和原位移植小鼠模型中均显著抑制人肝细胞癌。
J Exp Clin Cancer Res. 2016 May 6;35:74. doi: 10.1186/s13046-016-0353-8.
10
Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.携带粘着斑激酶短发夹RNA的双调控溶瘤腺病毒靶向肝细胞癌的基因治疗
Int J Oncol. 2015 Aug;47(2):668-78. doi: 10.3892/ijo.2015.3047. Epub 2015 Jun 12.

引用本文的文献

1
An automated and high-throughput approach for enhanced precision of adenoviral titering.一种提高腺病毒滴定精度的自动化高通量方法。
Mol Ther Methods Clin Dev. 2025 Jan 20;33(1):101410. doi: 10.1016/j.omtm.2025.101410. eCollection 2025 Mar 13.
2
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches.使用微针贴片进行肽载体化肿瘤裂解物疫苗的透皮给药。
Bioact Mater. 2024 Nov 19;45:115-127. doi: 10.1016/j.bioactmat.2024.11.006. eCollection 2025 Mar.
3
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

本文引用的文献

1
Design and application of oncolytic viruses for cancer immunotherapy.溶瘤病毒在癌症免疫治疗中的设计与应用。
Curr Opin Biotechnol. 2020 Oct;65:25-36. doi: 10.1016/j.copbio.2019.11.016. Epub 2019 Dec 23.
2
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer.溶瘤病毒治疗与免疫系统:抗癌的双刃剑。
Front Immunol. 2018 Apr 26;9:866. doi: 10.3389/fimmu.2018.00866. eCollection 2018.
3
Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
用细胞因子武装的腺病毒增强肾细胞癌中的 T 细胞募集。
Oncoimmunology. 2024 Sep 25;13(1):2407532. doi: 10.1080/2162402X.2024.2407532. eCollection 2024.
4
Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries.将CRISPR-Cas介导的末端切割与一种新型遗传工作流程相结合,以构建高多样性腺病毒文库。
Mol Ther Methods Clin Dev. 2024 Mar 18;32(2):101241. doi: 10.1016/j.omtm.2024.101241. eCollection 2024 Jun 13.
5
Oncolytic virotherapy in cancer treatment: challenges and optimization prospects.肿瘤溶瘤病毒治疗癌症:挑战与优化前景。
Front Immunol. 2023 Dec 15;14:1308890. doi: 10.3389/fimmu.2023.1308890. eCollection 2023.
6
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.通过对鼠源性和人源性间皮瘤肿瘤的免疫肽组学分析,开发出了间皮瘤特异性溶瘤免疫疗法。
Nat Commun. 2023 Nov 3;14(1):7056. doi: 10.1038/s41467-023-42668-7.
7
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.使用溶瘤腺病毒对增强型交叉杂交IgGA Fc PD-L1抑制剂进行控释。
Mol Ther Oncolytics. 2023 Feb 5;28:264-276. doi: 10.1016/j.omto.2023.01.006. eCollection 2023 Mar 16.
8
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.肽涂层溶瘤疫苗用于癌症个体化医疗。
Front Immunol. 2022 Apr 14;13:826164. doi: 10.3389/fimmu.2022.826164. eCollection 2022.
9
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.表达增强型交叉杂交 IgGA Fc PD-L1 抑制剂的新型溶瘤腺病毒在体外、体内和患者来源的肿瘤类器官中激活多种免疫效应细胞群,从而增强肿瘤杀伤作用。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-003000.
10
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.病毒分子模拟影响鼠类和人类黑色素瘤的抗肿瘤免疫反应。
Cancer Immunol Res. 2021 Aug;9(8):981-993. doi: 10.1158/2326-6066.CIR-20-0814. Epub 2021 Jun 8.
腺病毒介导的基因递送:个性化医疗新时代中基于基因和细胞疗法的潜在应用。
Genes Dis. 2017 Jun;4(2):43-63. doi: 10.1016/j.gendis.2017.04.001. Epub 2017 Apr 27.
4
Implementing Genome-Driven Oncology.实施基因组驱动的肿瘤学。
Cell. 2017 Feb 9;168(4):584-599. doi: 10.1016/j.cell.2016.12.015.
5
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.靶向肿瘤微环境:消除抗肿瘤免疫反应和免疫治疗的障碍。
Ann Oncol. 2016 Aug;27(8):1482-92. doi: 10.1093/annonc/mdw168. Epub 2016 Apr 10.
6
Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.通过对腺病毒表面进行基因、化学和机械修饰来改变腺病毒嗜性用于癌症基因治疗。
Expert Opin Drug Deliv. 2016 Jun;13(6):843-58. doi: 10.1517/17425247.2016.1158707. Epub 2016 Mar 16.
7
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.替莫唑胺胶丸联合放疗治疗恶性脑胶质瘤的疗效观察
J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26.
8
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.腺病毒载体用于基因治疗、疫苗接种和癌症基因治疗。
Curr Gene Ther. 2013 Dec;13(6):421-33. doi: 10.2174/1566523213666131125095046.
9
Adenovirus virion stability and the viral genome: size matters.腺病毒病毒体稳定性与病毒基因组:大小至关重要。
Mol Ther. 2009 Oct;17(10):1664-6. doi: 10.1038/mt.2009.202.
10
Enzymatic assembly of DNA molecules up to several hundred kilobases.长达数百千碱基的DNA分子的酶促组装。
Nat Methods. 2009 May;6(5):343-5. doi: 10.1038/nmeth.1318. Epub 2009 Apr 12.